Paper Review Records
All Paper Review Records
29 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
8
days
Daraxonrasib: First Approval
Authors
Yahiya Y. SyedShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
11
days
Insulin Efsitora Alfa: First Approval
Authors
Hannah A. BlairShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
25
days
Oveporexton: First Approval
Authors
Michael B. BrownShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
24
days
Enlicitide: First Approval
Authors
Hannah A. BlairShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
30
days
Iberdomide: First Approval
Authors
Hannah A. BlairShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
19
days
Pariglasgene Brecaparvovec: First Approval
Authors
Arnold LeeShow moreShow less
Affiliations
1. Springer Nature, Auckland, New ZealandShow moreShow less
FAQ
How long does DRUGS take to review a manuscript?
As of 2026-11-18, CrushSCI has 29 complete review records for DRUGS. The fastest paper went from submission to acceptance in 7 days (Rovadicitinib: First Approval, received 2026-04-27, accepted 2026-05-04); the slowest took 350 days. The average is 99.4 days and the median is 53 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
